article thumbnail

What’s Next for Psychedelic Medicines?

MedCity News

After the FDA delayed the approval of MDMA-assisted therapy for PTSD, there’s still a way forward for psychedelic medicines, experts said at HLTH. The post What’s Next for Psychedelic Medicines? appeared first on MedCity News.

Medicine 125
article thumbnail

After Roche breakup, Blueprint Medicines finds Gavreto a new home at Rigel

Fierce Pharma

As Roche officially abandoned cancer drug Gavreto, its former partner Blueprint Medicines has found the RET inhibitor a new owner in the U.S. | As Roche officially abandoned cancer drug Gavreto, its former partner Blueprint Medicines has found the RET inhibitor a new U.S. owner in Rigel Pharmaceuticals.

Medicine 283
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

4 Things Employers Should Know About Psychedelic Medicines

MedCity News

During a panel discussion at the Behavioral Health Tech conference, experts shared the promise psychedelic medicines hold for mental health and why employers may want to consider offering them as a workplace benefit. The post 4 Things Employers Should Know About Psychedelic Medicines appeared first on MedCity News.

Medicine 112
article thumbnail

Europe names hundreds of critical medicines in quest to counter drug shortages

Fierce Pharma

Tuesday, the European Medicines Agency laid out a list of more than 300 critical generic drugs that could fall prey to future shortages. Over the past several years, drug shortages have vexed doctors and patients on both sides of the Atlantic, prompting lawmakers and government agencies to take action in both Europe and the U.S.

Medicine 358
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine.

article thumbnail

What’s the Impact of Data Modernization and AI on Precision Medicine?

Fierce Pharma

In this interview, Kavitha Lokesh, Vice President of Global Life Sciences R&D Industry Solutions at Cognizant, discusses her role and the impact of precision medicine.

Medicine 130
article thumbnail

NationsBenefits Acquires Good Measures to Advance Food-as-Medicine Offerings

MedCity News

To ramp up its food-as-medicine support, NationsBenefits has acquired Good Measures, a company that offers coaching and personalized food prescriptions. The post NationsBenefits Acquires Good Measures to Advance Food-as-Medicine Offerings appeared first on MedCity News.

Food 90